<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05005767</url>
  </required_header>
  <id_info>
    <org_study_id>2D</org_study_id>
    <nct_id>NCT05005767</nct_id>
  </id_info>
  <brief_title>Effect of Frankincense Extract Gel on Non-Surgical Treatment of Chronic Periodontitis</brief_title>
  <official_title>The Adjunctive Effect of Frankincense Extract Gel on Non-Surgical Treatment of Chronic Periodontitis: Clinical and Microbiological Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the effect of the subgingival application of Frankincense extract&#xD;
      gel as an adjunct to scaling and root planning (SRP) in chronic periodontitis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      : twenty patients will be randomly selected and equally divided into Group I: will receive&#xD;
      SRP only, group II: will receive SRP and Frankincense extract the gel. Subgingival&#xD;
      application of Frankincense extract gel will be performed following initial SRP )day 1) and&#xD;
      at 7, and 14 days. Clinical measurements included pocket depth (PD), bleeding on probing&#xD;
      (BOP), and clinical attachment level (CAL). Real-time PCR was carried out to determine the&#xD;
      effect of the treatment on Porphyromonas gingivalis (Pg). Clinical measurements and Plaque&#xD;
      samples for PCR were recorded at baseline (before treatment), one, and three months after&#xD;
      treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 1, 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>twenty patients will be randomly be selected and equally divided into Group I: will receive SRP only, group II: will receive SRP and Frankincense extract the gel. Subgingival application of Frankincense extract gel will be performed following initial SRP )day 1) and at 7, and 14 days.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>probing pocket depth</measure>
    <time_frame>baseline</time_frame>
    <description>probing pocket depth will be recorded at baseline, at site that will be treated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>probing pocket depth</measure>
    <time_frame>1 month</time_frame>
    <description>probing pocket depth will be recorded at 1 month at the site to be treated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>probing pocket depth</measure>
    <time_frame>3 month</time_frame>
    <description>probing pocket depth will be recorded at 3 month at the site to be treated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>clinical attachment level</measure>
    <time_frame>baseline</time_frame>
    <description>clinical attachment level will be recorded at baseline,</description>
  </primary_outcome>
  <primary_outcome>
    <measure>clinical attachment level</measure>
    <time_frame>1 month</time_frame>
    <description>clinical attachment level will be recorded at , 1 month at the site to be treated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>clinical attachment level</measure>
    <time_frame>3 month</time_frame>
    <description>clinical attachment level will be recorded at 3 months at the site to be treated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>bleeding on probing</measure>
    <time_frame>baseline</time_frame>
    <description>bleeding on probingwill be recorded at baseline, at the site to be treated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>bleeding on probing</measure>
    <time_frame>1 month</time_frame>
    <description>bleeding on probingwill be recorded at 1, month at the site to be treated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>bleeding on probing</measure>
    <time_frame>3 month</time_frame>
    <description>bleeding on probingwill be recorded at 3 months at the site to be treated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PCR for Porphyromonas gingivalis count</measure>
    <time_frame>baseline</time_frame>
    <description>PCR for Porphyromonas gingivalis count be recorded at baseline, at the site to be treated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PCR for Porphyromonas gingivalis count</measure>
    <time_frame>1 month</time_frame>
    <description>PCR for Porphyromonas gingivalis count be recorded at 1, and month at the site to be treated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PCR for Porphyromonas gingivalis count</measure>
    <time_frame>3 month</time_frame>
    <description>PCR for Porphyromonas gingivalis count be recorded at 3 months at the site to be treated</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Chronic Periodontitis</condition>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>ten patients with sites suffering from mild chronic periodontitis sites will be treated with scaling and root planing (SRP) only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>test group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ten patients with sites suffering from mild chronic periodontitis. sites will be treated with scaling and root planing (SRP) and subgingival application of Frankincense extract gel</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>scaling and root planing</intervention_name>
    <description>will receive scaling and root planing only</description>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_label>test group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Frankincense extract gel natural herbal product</intervention_name>
    <description>will receive Scaling and root planing then. Subgingival application of Frankincense extract gel</description>
    <arm_group_label>test group</arm_group_label>
    <other_name>Scaling and root planing</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  systemically healthy patients were selected&#xD;
&#xD;
          -  patients who had not received any medications for the previous six months that may&#xD;
             interfere with periodontal tissue health or healing.&#xD;
&#xD;
          -  Patients should demonstrate their ability to maintain good oral hygiene&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Smokers and pregnant patients.&#xD;
&#xD;
          -  Medically compromised patients and systemic conditions precluding periodontal surgery.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Doaa Ahmed yousef bayoumi</name>
      <address>
        <city>Tanta</city>
        <state>Gharbiya</state>
        <zip>31511</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 31, 2021</study_first_submitted>
  <study_first_submitted_qc>August 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 16, 2021</study_first_posted>
  <last_update_submitted>August 10, 2021</last_update_submitted>
  <last_update_submitted_qc>August 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tanta University</investigator_affiliation>
    <investigator_full_name>Doaa Ahmed Yousef</investigator_full_name>
    <investigator_title>lecturer at Periodontology, oral medicine, diagnosis and radiology department</investigator_title>
  </responsible_party>
  <keyword>chronic periodontitis.</keyword>
  <keyword>Frankincense</keyword>
  <keyword>non surgical treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Chronic Periodontitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

